Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shou Zu Ning No. 1 Formula is a Traditional Chinese Medicine (TCM) herbal preparation primarily utilized for the prevention and treatment of hand-foot syndrome (HFS), also known as palmar-plantar erythrodysesthesia (PPE). This condition is a common dermatological toxicity associated with chemotherapy agents such as capecitabine and targeted therapies like sorafenib or sunitinib. The formula is typically administered as a topical soak or wash and is designed to alleviate symptoms including erythema, edema, pain, and desquamation of the extremities. Developed and extensively studied at institutions like Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine, the formula acts by clearing heat, detoxifying, and promoting local blood circulation to mitigate the inflammatory response in the skin tissues of the hands and feet.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shou Zu Ning No. 1 Formula.